Drug Class
EGFR and MET bispecific antibody
Type
brand
Active Ingredient
amivantamab
📋Overview
Rybrevant is a monoclonal antibody used in the management of certain types of non-small cell lung cancer. It targets specific genetic alterations in cancer cells, particularly those involving the EGFR exon 20 insertion mutation. By binding to these targets, Rybrevant helps to interfere with cancer cell growth and survival. This medication is typically considered when other treatment options are limited or have not been effective.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Rybrevant
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.